Aemetis (NASDAQ:AMTX) Shares Cross Below 200 Day Moving Average – Should You Sell?

Aemetis, Inc (NASDAQ:AMTX) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.97 and traded as low as $1.41. Aemetis shares last traded at $1.42, with a volume of 481,297 shares changing hands.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on AMTX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a report on Wednesday, January 21st. Ascendiant Capital Markets lowered their price target on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $17.00.

Aemetis Trading Down 3.4%

The business has a 50-day moving average price of $1.52 and a two-hundred day moving average price of $1.97. The stock has a market capitalization of $94.00 million, a P/E ratio of -0.88 and a beta of 2.66.

Institutional Investors Weigh In On Aemetis

A number of large investors have recently bought and sold shares of the company. Ethic Inc. acquired a new position in shares of Aemetis in the 2nd quarter valued at approximately $42,000. Qube Research & Technologies Ltd bought a new position in shares of Aemetis in the 2nd quarter valued at $246,000. Bridgeway Capital Management LLC grew its position in Aemetis by 96.3% in the third quarter. Bridgeway Capital Management LLC now owns 101,900 shares of the specialty chemicals company’s stock valued at $229,000 after acquiring an additional 50,000 shares during the last quarter. Russell Investments Group Ltd. increased its position in Aemetis by 412.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company’s stock worth $200,000 after purchasing an additional 65,010 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Aemetis during the fourth quarter worth $52,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.